Vaccine 411 for 6-23-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

This is Vaccine 4-1-1.  As the race for a COVID-19 vaccine continues, here are the numbers:

142 vaccines are in development, according to The World Health Organization and The New York Times

128 are in pre-clinical trials. 

5 are in Phase 1 Clinical Trials.

7 are in Phase 2.

2 are in Phase 3. One in the United Kingdom and one in Australia.

On this episode of Vaccine 411… Could a booster of a childhood vaccine you probably already have protect you from the virus?

First, the latest vaccine news from around the world: 

United States: The race for the COVID-19 vaccine could be held up by a glass shortage. Many of the vaccines in clinical trials require a glass vial for distribution. In order to avoid any kind of backup, BARDA a Federal Government program, has allocated 204 million dollars to Corning to produce an additional 164 million vials a year if needed. 

China: Clover Biopharmaceuticals, entered Phase I human trials with their vaccine candidate. The Chinese based company will begin the trials in Perth Australia with 150 healthy adults. Preliminary data is expected in August. They hope to enter Phase IIb/III trials by the end of the year. 

Thailand: Thirteen monkeys were given a second dose of a potential COVID-19 vaccine, reports Reuters. The monkeys were given the first dose in late May, all but one from the “high dose group” had a positive response. The animals will be monitored over the next two weeks and if the second dose again creates a high immune response, the Thai Government will order 10,000 doses with a mid to late Fall target to begin Phase I human trials. 

Now…Tell me about your childhood.  

Hosted on Acast. See acast.com/privacy for more information.